A/Prof Rachel Koldej
Clinical (Associate Professor)
Department of Medicine
112 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
Marginal Zone Lymphoma is associated with dysregulated T cell immunity which is not altered by ibrutinib-venetoclax treatment
DOI: 10.1016/j.bneo.2026.1002602026
Journal article
Identification of T:B Cell Multimers After Bispecific T Cell Engagement, Using Both Conventional and Imaging Flow Cytometry
DOI: 10.1002/cyto.a.700392026
Journal article
Who will watch the watchmen: unique challenges of T-cell redirecting therapies in T-cell malignancies
DOI: 10.1016/S2352-3026(26)00005-02026
Journal article
Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma
DOI: 10.1182/bloodadvances.20250166462026
Research contracts (non-grants)
Developing Translational Insights Into Poor Graft Function Following Allogeneic Stem Cell Transplantation
2026
Journal article
T cell and monocyte activation in concert with hematopoietic stem cell interactions shapes the post-allogeneic transplant immune landscape in poor graft function
DOI: 10.3389/fimmu.2026.17500932025
Other
Supplementary Data DS1 from A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study
DOI: 10.1158/1078-0432.30707564
RECENT SCHOLARLY WORKS
2025
Conference Proceedings
Utilisation of machine learning algorithms to predict relapse risk following allogeneic stem cell transplantation (alloSCT) for patients with myeloid malignancies
DOI: 10.1182/blood-2025-60812025
Conference Proceedings
Immunological responses to blinatumomab treatment in B-acute lymphoblastic leukaemia (B-ALL) patients - australasian leukemia and lymphoma group ALL08 blam study
DOI: 10.1182/blood-2025-33412025
Journal article
T-cell immune profile changes predict durable response to nivolumab-rituximab in treatment-naïve FL
DOI: 10.1016/j.bneo.2025.1001682025
Journal article
Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and Cyclosporin.
DOI: 10.1056/NEJMoa2503189
RECENT PROJECTS
2015
Research Grant
Circulating microRNA as a Biomarker in Brain Cancer